← Back to Search

Peer Support + Mobile App for HIV/AIDS (PATH Trial)

N/A

Waitlist Available

Research Sponsored by San Diego State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥18 years old

One or more detectable viral load test result (>200 copies m/L) in the past 12-months while on antiretroviral therapy for at least 3 months

Must not have

<18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether a combination of peer support and mobile technology can help improve HIV care outcomes for Hispanic and Black patients.

Who is the study for?

This trial is for Hispanic and Black adults living with HIV who are over 18, speak English or Spanish, on HIV medication, have internet access, and plan to stay in San Diego for the next year. They must have had treatment challenges like detectable viral loads while on therapy, missed appointments, infrequent care visits or low adherence to their antiretroviral regimen.

What is being tested?

The PATH study is a randomized controlled trial testing an intervention that combines peer support with a mobile app designed to improve the management of HIV care among participants. It aims to see if this approach can help patients better adhere to treatments and maintain their health.

What are the potential side effects?

Since this trial focuses on a non-medical intervention involving peer navigation and use of a mobile app, traditional side effects related to drugs are not applicable. However, there may be privacy concerns or emotional impacts from using the app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have had a detectable viral load while on HIV medication for over 3 months.

Select...

I am currently taking medication for HIV.

Select...

I have been diagnosed with HIV by a doctor.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Viral suppression

Secondary study objectives

Antiretroviral therapy adherence

Gap in HIV medical visits

Retention in HIV care

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Usual CareActive Control1 Intervention

Participants assigned to this group are in the control arm and will receive standard of care following the Ryan White model of care.

Group II: PATH Active Intervention ArmActive Control1 Intervention

Participants assigned to this group will receive care as usual if they are assigned to this group. In addition, participants in this arm will receive HIV care support from a trained peer navigator and have access to a mHealth web application designed to support their health and HIV care.

0 / 5Eligibility criteria met